Les nouveaux traitements de l'hépatite C

Therapy against HCV has recently entered in a new era, with the development of new direct acting antivirals agents (DAA) which succeed in curing the large majority of the treated patients. This paper will review these major advances, detailing the new molecules and combinations that are available and focusing on the next issues of the future.